ASCENEURON S A has a total of 38 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are HEXAPHARMATEC CO LTD, XUANZHU PHARMA CO LTD and GPI NIL HOLDINGS.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 12 | |
#2 | Australia | 6 | |
#3 | Canada | 6 | |
#4 | Mexico | 5 | |
#5 | China | 4 | |
#6 | Singapore | 4 | |
#7 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Quattropani Anna | 33 |
#2 | Giri Awadut Gajendra | 32 |
#3 | Kulkarni Santosh S | 32 |
#4 | Crowe David Malcolm | 8 |
#5 | Koek Johannes Nicolaas | 5 |
#6 | Awadut Gajendra Giri | 5 |
#7 | Santosh S Kulkarni | 5 |
#8 | Anna Quattropani | 5 |
#9 | Hett Robert | 4 |
#10 | Toronto Dawn V | 4 |
Publication | Filing date | Title |
---|---|---|
WO2020039029A1 | Spiro compounds as glycosidase inhibitors | |
WO2020039027A1 | Pyrrolidine glycosidase inhibitors | |
WO2020039028A1 | Tetrahydro-benzoazepine glycosidase inhibitors | |
AU2019324522A1 | Succinate and fumarate acid addition salts of piperazine derivatives useful as glycosidase inhibitors | |
WO2019037861A1 | Annulated glycosidase inhibitors | |
EP3585779A1 | Substituted dihydrobenzofuran glycosidase inhibitors | |
MX2018010192A | Glycosidase inhibitors. | |
AU2017222964A1 | Glycosidase inhibitors |